Positive Peritoneal Cytology
Showing 1 - 25 of >10,000
Gastric Adenocarcinoma, Esophagogastric Junction, Gastric Cancer Trial run by the National Cancer Institute (NCI) (Surgery,
Recruiting
- Gastric Adenocarcinoma
- +2 more
- Surgery
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Endometrial Cancer Trial in York (surgical staging)
Recruiting
- Endometrial Cancer
- surgical staging
-
York, PennsylvaniaWellspan Health
Jun 2, 2022
Pancreatic Adenocarcinoma Trial in Seattle (Gemcitabine, nab-paclitaxel)
Recruiting
- Pancreatic Adenocarcinoma
-
Seattle, WashingtonVirginia mason medical Center
Jul 19, 2021
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Peritoneal Carcinomatosis Trial in Houston (Cisplatin,
Active, not recruiting
- Gastric Adenocarcinoma
- +2 more
- Cisplatin
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Apr 12, 2022
Gastric Adenocarcinoma, Carcinomatosis Trial in Houston (Paclitaxel, Dexamethasone, Diphenhydramine)
Not yet recruiting
- Gastric Adenocarcinoma
- Carcinomatosis
- Paclitaxel
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Aug 7, 2023
Cervix Cancer, HPV Testing, Postmenopausal Women Trial in Randers (cytology, p16/ki67 dual stain cytology (DS), extended
Recruiting
- Cervix Cancer
- +2 more
- cytology, p16/ki67 dual stain cytology (DS), extended genotyping, DNA methylation, viral load,
-
Randers, Central Denmark Region, DenmarkDepartment of Pathology
Feb 3, 2023
Papilloma-induced Cervical Lesions Trial in Scorrano (EGCG, FA, HA, B12)
Enrolling by invitation
- Papilloma-induced Cervical Lesions
- EGCG, FA, HA, B12
-
Scorrano, Lecce, ItalyOspedale Veris delli Ponti
Oct 24, 2023
Pancreatic Cancer, Pancreatic Adenocarcinoma Trial in Odense
Recruiting
- Pancreatic Cancer
- Pancreatic Adenocarcinoma
-
Odense, DenmarkOdense University Hospital
Jun 5, 2022
Diseases of Oesophagus Stomach and Duodenum Trial in Houston (Dexamethasone, Diphenhydramine, Famotidine)
Active, not recruiting
- Diseases of Oesophagus Stomach and Duodenum
- Dexamethasone
- +5 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 7, 2022
Gastric Cancer, Peritoneal Metastases, Chemo Effect Trial in London (Doxorubicin and Cisplatin)
Not yet recruiting
- Gastric Cancer
- +2 more
- Doxorubicin and Cisplatin
-
London, United KingdomImperial College London, Hammersmith Hospital Campus
Apr 1, 2022
Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma Trial in Beijing (Niraparib)
Recruiting
- Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma
-
Beijing, Beijing, ChinaPeking University Cancer Hospital
Nov 15, 2023
Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial (Mirvetuximab soravtansine plus Bevacizumab, Bevacizumab)
Recruiting
- Ovarian Cancer
- +2 more
- Mirvetuximab soravtansine plus Bevacizumab
- Bevacizumab
-
New Orleans, Louisiana
- +3 more
Dec 16, 2022
High Grade Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer Trial (Mirvetuximab soravtansine, Carboplatin)
Not yet recruiting
- High Grade Ovarian Cancer
- +2 more
- Mirvetuximab soravtansine
- Carboplatin
- (no location specified)
Jul 11, 2022
Stomach Tumor, Peritoneal Carcinomatosis Trial in Amsterdam (Cytoreductive surgery + Gastrecomy, Hyperthermic Intraperitoneal
Recruiting
- Stomach Neoplasm
- Peritoneal Carcinomatosis
- Cytoreductive surgery + Gastrecomy
- Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
-
Amsterdam, NetherlandsAntoni van Leeuwenhoek/ Netherlands Cancer institute
Feb 14, 2022
Advanced Epithelial Ovarian, Recurrent Epithelial Ovarian, Fallopian Tube Trial in United States (Enzalutamide)
Completed
- Advanced Epithelial Ovarian
- +3 more
-
Basking Ridge, New Jersey
- +5 more
Mar 4, 2022
Ovarian Cancer, Fallopian Tube, Primary Peritoneal Cancer Trial in Birmingham (mirvetuximab soravtansine (MIRV; IMGN853))
Recruiting
- Ovarian Cancer
- +2 more
- mirvetuximab soravtansine (MIRV; IMGN853)
-
Birmingham, AlabamaUniversity of Alabama at Birmingham Womens & Infants Center
Jun 30, 2022
Gastric Cancer, Gastric Adenocarcinoma, Peritoneal Carcinomatosis Trial in Montréal, Quebec City (Indocyanine green)
Recruiting
- Gastric Cancer
- +3 more
- Indocyanine green
-
Montréal, Quebec, Canada
- +1 more
Jan 8, 2023
Metastatic Pancreatic Carcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Rochester (Cisplatin, Hyperthermic Intraperitoneal
Not yet recruiting
- Metastatic Pancreatic Carcinoma
- Stage IV Pancreatic Cancer AJCC v8
- Cisplatin
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 6, 2023
BRCA1 Gene Mutation, BRCA2 Gene Mutation, Folate Receptor Alpha Positive Trial in Columbus (other, biological, drug)
Active, not recruiting
- BRCA1 Gene Mutation
- +9 more
- Laboratory Biomarker Analysis
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Sep 16, 2022
Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal
Active, not recruiting
- Platinum-Resistant Fallopian Tube Carcinoma
- +11 more
- Aldesleukin
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 13, 2022
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Metastatic Malignant Tumor in the Peritoneum Trial in
Not yet recruiting
- Gastric Adenocarcinoma
- +2 more
- Biospecimen Collection
- +8 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Mar 2, 2023
Peritoneum; Carcinomatosis, Peritoneal Tumors, Peritoneal Metastases Trial in Odense (PIPAC)
Completed
- Peritoneum; Carcinomatosis
- +6 more
-
Odense, DenmarkDepartment of Surgery, Odense University Hospital
Oct 5, 2022
Oligometastatic Gastric Adenocarcinoma Trial in Verona (FOLFOX and PIPAC)
Recruiting
- Oligometastatic Gastric Adenocarcinoma
- FOLFOX and PIPAC
-
Verona, ItalyAOUI Verona
Jul 19, 2022
Peritoneal Carcinoma Metastatic, Pleural Effusion, Malignant Trial in Chengdu (Dual-targeting HER2 and PD-L1 CAR-T cells)
Active, not recruiting
- Peritoneal Carcinoma Metastatic
- Pleural Effusion, Malignant
- Dual-targeting HER2 and PD-L1 CAR-T cells
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Sep 21, 2021
Peritoneal Micrometastasis in Gastric and Pancreatic Cancer in
Active, not recruiting
- Gastric and Pancreatic Cancer
- washings for experimental marker testing
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Oct 1, 2021